Nitazoxanide and Ofloxacin Tablet
Generic Name |
Nitazoxanide and Ofloxacin |
---|---|
Strength |
500 mg +200 mg |
Form |
Tablet |
Packaging |
1 X 10 Tablet |
Therapeutic use |
Anti Diarrheal, Anti Parasitic, Urinary tract infections |
Manufacturing Period |
30 to 45 Days |
Available Composition of
Name | Strength | Therapeutic use | View More |
---|---|---|---|
Nitazoxanide and Ofloxacin Tablet | 500 mg + 200 mg | Anti Diarrheal, Anti Parasitic, Urinary tract infections | |
Nitazoxanide Tablet | 200 mg, 500 mg | Anti Diarrheal, Anti Parasitic | |
Cefpodoxime Proxetil and Ofloxacin Tablet | 200 mg + 200 mg | Antibiotic | |
Cefpodoxime and Ofloxacin Tablet | 200 mg + 200 mg | Antibiotic | |
Cefixime and Ofloxacin Tablet | 200 mg + 200 mg | Antibiotic, GI tract infection, Respiratory tract infection, Urinary tract infections | |
Cefixime and Ofloxacin Suspension | 50 mg + 50 mg | Antibiotic |
Product Description For Nitazoxanide and Ofloxacin Tablet
products details and uses
Nitazoxanide and Ofloxacin Tablet Exporter India, Manufacturer and Global Supplier
As a trusted Nitazoxanide and Ofloxacin Tablet Exporter India, we provide high-quality combination tablets designed to combat both bacterial and protozoal infections. This dual-action formulation combines Nitazoxanide, a broad-spectrum anti-parasitic agent, with Ofloxacin, a fluoroquinolone antibiotic, offering comprehensive treatment for gastrointestinal and urinary tract infections. Manufactured under WHO-GMP certified facilities, our tablets ensure safety, efficacy, and consistent quality for global healthcare providers.
Uses of Nitazoxanide and Ofloxacin Tablet
This combination tablet is widely prescribed for a variety of infections, including:
-
Acute Gastroenteritis – Effective in treating diarrhea and stomach infections caused by bacteria and protozoa.
-
Giardiasis and Amoebiasis – Treats infections caused by Giardia lamblia and Entamoeba histolytica.
-
Urinary Tract Infections (UTIs) – Ofloxacin component combats bacterial causes of UTIs.
-
Traveler’s Diarrhea – Provides rapid relief from acute diarrhea during travel.
-
Mixed Intestinal Infections – Offers dual-action therapy for infections involving multiple pathogens.
Our position as a reliable Nitazoxanide and Ofloxacin Tablet Exporter India ensures healthcare facilities have access to effective and affordable combination therapy worldwide.
Precautions Before Use
-
Always use under medical supervision.
-
Complete the full course of therapy to prevent recurrence or resistance.
-
Patients with liver or kidney impairment should consult their physician.
-
Not recommended for children under the prescribed age unless directed by a doctor.
-
Pregnant and breastfeeding women must seek medical advice before administration.
-
Avoid simultaneous use of other fluoroquinolones unless prescribed.
As a responsible Nitazoxanide and Ofloxacin Tablet Exporter India, we provide complete product leaflets and instructions for safe usage.
Possible Side Effects
Nitazoxanide and Ofloxacin tablets are generally well tolerated, though some patients may experience mild side effects:
-
Nausea, vomiting, or stomach discomfort
-
Headache or dizziness
-
Mild skin rash or itching
-
Temporary discoloration of urine (due to Nitazoxanide)
-
Rare allergic reactions or tendon discomfort (due to Ofloxacin)
Most side effects are temporary and resolve without intervention, but severe reactions require immediate medical attention.
Why Choose Us as Your Nitazoxanide and Ofloxacin Tablet Exporter India?
-
WHO-GMP certified manufacturing ensuring international quality standards.
-
Regulatory support including COA, SmPC, and technical dossiers.
-
Flexible packaging solutions for hospitals, clinics, and bulk distribution.
-
Global logistics expertise ensuring timely delivery across Asia, Africa, CIS, and the Middle East.
-
Competitive pricing without compromising quality.
Global Distribution Network
With a strong logistics and compliance framework, we successfully export to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.